Intelligent control and operation and maintenance method and system of immune cell culture device
By constructing a simulation model and chemokine analysis of the immune cell culture device, a full-cycle culture environment control solution was generated, which solved the problem of low efficiency of precise control and operation and maintenance of traditional equipment, and achieved efficient cultivation and operation and maintenance optimization of immune cells.
Patent Information
- Application Number
- CN202411100180.0
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-12
- Publication Date
- 2024-12-06
- Estimated Expiration
- 2044-08-12
AI Technical Summary
Traditional immune cell culture equipment is difficult to achieve precise environmental parameter control and nutritional component supply required for different proliferation and growth stages, resulting in a decrease in the proliferation activity and survival rate of immune cells and low operation and maintenance efficiency.
By constructing a simulation model of the immune cell culture device, analyzing the physiological characteristics parameters of chemokine, generating a full-cycle culture environment control scheme, adjusting the nutritional supply content parameters, and performing operation and maintenance calibration based on the simulated dynamic travel control model to achieve intelligent control.
Accurately control the culture environment and nutritional supply of immune cells, improve the proliferation activity and survival rate of immune cells, improve operation and maintenance efficiency, and ensure the quality of culture.
Smart Images

Figure CN118621068B_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to the technical field of immune cell culture equipment, and in particular to an intelligent control and operation and maintenance method and system for an immune cell culture device. Background Art
[0002] Immune cell culture devices are devices used to simulate the culture and study of immune cells. Immune cells play a key role in the immune system. In order to more efficiently and feasibly study and analyze the functions, behaviors and roles of immune cells in diseases, targeted culture devices can be used to simulate a growth environment suitable for the proliferation of immune cells. However, traditional immune cell culture devices have poor simulation effects on the proliferation and growth environment required for immune cells during the culture process. This is mainly reflected in the difficulty in achieving precise control of the culture environment parameters required for different proliferation and growth stages, as well as accurate supply control of the nutrient content required for different proliferation and growth stages. This has greatly reduced the proliferation activity and survival rate of immune cells cultured with traditional equipment, affecting the functions and therapeutic effects of immune cells. At the same time, the operation and maintenance of traditional equipment usually requires manual inspection and maintenance of each device mechanism in the equipment for abnormal operation and control, which reduces the efficiency of operation and maintenance and is time-consuming and labor-intensive. Summary of the invention
[0003] The present invention overcomes the deficiencies of the prior art and provides an intelligent control and operation and maintenance method and system for an immune cell culture device.
[0004] To achieve the above object, the technical solution adopted by the present invention is:
[0005] A first aspect of the present invention provides an intelligent control and operation and maintenance method for an immune cell culture device, comprising the following steps:
[0006] Construct a simulation model of an immune cell culture device to simulate the culture in the whole cycle to obtain a target immune cell culture model at each proliferation node, analyze the migration activity through the target immune cell culture model and the physiological characteristic parameters of chemokines, and obtain a type I active immune cell and a type II active immune cell;
[0007] Analyze the control deviation of the culture environment parameter set corresponding to the target immune cells at each proliferation node based on the first type of active immune cells and the second type of active immune cells, and generate a culture environment control plan for the entire cycle of the target immune cells;
[0008] Obtaining proliferation image data of target immune cells on each proliferation node after running the culture environment control scheme, adjusting the nutrient supply content parameters required for culturing target immune cells based on the difference analysis between the actual proliferation texture contrast and the reference proliferation texture contrast of the proliferation image data on adjacent proliferation nodes, and generating a culture environment control scheme for the full cycle of target immune cells;
[0009] Based on the culture environment control scheme and the simulation operation of the culture environment control scheme, the simulated dynamic stroke control models of different sub-culture devices in the immune cell culture device in the preset culture area are obtained, and the actual dynamic stroke control model of the current culture node is obtained at the same time. The immune cell culture device is operated and calibrated according to the model deviation between the actual dynamic stroke control model and the corresponding simulated dynamic stroke control model to obtain an operation and maintenance plan.
[0010] Furthermore, in a preferred embodiment of the present invention, the simulation model of the immune cell culture device is constructed to simulate the culture in the whole cycle to obtain the target immune cell culture model at each proliferation node, and the migration activity is analyzed by the target immune cell culture model and the physiological characteristic parameters of the chemokines to obtain the first type of active immune cells and the second type of active immune cells, which specifically includes the following steps:
[0011] Acquire a culture case of target immune cells from a big data network, initialize preset culture parameters of an immune cell culture device based on the culture case, and generate a preset culture strategy for the target immune cells;
[0012] Obtaining the growth cycle law of target immune cells, presetting multiple proliferation nodes of target immune cells based on the growth cycle law, constructing a simulation model of an immune cell culture device, using the simulation model to execute a preset culture strategy to perform full-cycle simulated culture of target immune cells, and extracting target immune cell culture models at various proliferation nodes during the full-cycle simulated culture process;
[0013] Obtain the type information of the target immune cells, and at the same time obtain the knowledge graph of the immune cell field based on the big data network, import the type information into the knowledge graph of the immune cell field for identification, and output the chemokines that can act on the target immune cells and multiple physiological characteristic parameters corresponding to each chemokine;
[0014] Acquire the culture environment parameters of the simulation model when executing the preset culture strategy at each proliferation node, introduce the particle swarm optimization algorithm to calculate the particle fitness function and the optimal position of the culture environment parameters and multiple physiological characteristic parameters corresponding to each chemokine, and obtain the particle fitness and the global optimal position;
[0015] Continuously updating and iterating the fitness of the current particle according to the global optimal position, obtaining the current iteration value, judging whether the current iteration value reaches a preset iteration threshold, and if so, outputting the final fitness of each particle, and constructing a chemokine signal release model for different proliferation culture environments according to the final fitness;
[0016] The chemokine signal release model is used to determine and analyze the migration activity of the target immune cell culture model at each proliferation node in response to the target chemokine, thereby obtaining a type I active immune cell and a type II active immune cell.
[0017] Furthermore, in a preferred embodiment of the present invention, the chemokine signal release model is used to determine and analyze the migration activity of the target immune cell culture model at each proliferation node in response to the target chemokine to obtain a type I active immune cell and a type II active immune cell, which specifically includes the following steps:
[0018] Preset a signal release frequency threshold and an ideal active migration duration of a target chemokine, and plan a signal release response range of the target chemokine based on the signal release frequency threshold;
[0019] The target immune cell culture model at each proliferation node is embedded in the corresponding proliferation node of the chemokine signal release model to perform migration analysis of the ideal active migration time, and the migration path of the target immune cells in different proliferation culture environments in response to the target chemokine signal at the ideal active migration time is extracted;
[0020] Detecting target immune cells on each proliferation node by confocal microscopy to draw a surface receptor distribution map of the target immune cells on each proliferation node, and planning the receptor perception range of the target immune cells on each proliferation node that can respond to and bind to the target chemokine based on the surface receptor distribution map;
[0021] Based on the migration path, the migration endpoint of the target immune cell under different proliferation environments is obtained, and it is determined whether the receptor perception range and the signal release response range intersect when the target immune cell reaches the migration endpoint. If so, it means that the target immune cell can bind to the target chemokine within the ideal active migration time, and the target immune cell is marked as a type of active immune cell;
[0022] If it does not exist, it means that the target immune cell cannot bind to the target chemokine within the ideal active migration time, and the target immune cell is labeled as a Class II active immune cell.
[0023] Further, in a preferred embodiment of the present invention, the control deviation of the culture environment parameter set corresponding to the target immune cells on each proliferation node is analyzed based on the first type of active immune cells and the second type of active immune cells to generate a culture environment control scheme for the entire cycle of the target immune cells, which specifically includes the following steps:
[0024] When the target immune cell on the proliferation node is a type of active immune cell, the intersection space model region between the receptor sensing range and the signal release response range of the target chemokine when the target immune cell reaches the migration end point is obtained;
[0025] Constructing a multidimensional space geometric topology field, performing geometric interpolation of multiple groups of preset control points on the intersection space model area in the multidimensional space geometric topology field to obtain a plurality of regional interpolations, and calculating the volume of the intersection space model area through the plurality of regional interpolation topologies to obtain a volume value of the intersection space model area;
[0026] Preset an ideal active migration path of the target immune cells, and obtain a standard intersection space model area volume value of a receptor perception range and a signal release response range when the target immune cells reach the ideal active migration path;
[0027] Calculate the difference between the volume value of the intersection space model area and the volume value of the standard intersection space model area to obtain a volume deviation value, and regulate the culture environment parameter set on the proliferation node corresponding to a type of active immune cells according to the volume deviation value to obtain a first culture environment regulation parameter set;
[0028] When the target immune cell on the proliferation node is a type II active immune cell, the migration path of the type II active immune cell in response to the target chemokine signal during the ideal active migration duration is obtained, and multiple uniform path segmentation points are preset;
[0029] Introducing a linear least squares method to calculate and fit a linear least squares model of the migration path and an ideal active migration path, calculating the sum of square errors at each uniform path segmentation point in the linear least squares model, and determining the path drift amplitude of the migration path compared to the ideal active migration path according to the sum of square errors of the path;
[0030] According to the path drift amplitude, a culture environment parameter set on the proliferation node corresponding to the second type of active immune cells is regulated to obtain a second culture environment regulation parameter set;
[0031] The node timing of each proliferation node is obtained based on the growth cycle law, and the first culture environment control parameter set and the second culture environment control parameter set on each proliferation node are spliced in time based on the node timing to generate a culture environment control plan for the entire cycle of target immune cells.
[0032] Furthermore, in a preferred embodiment of the present invention, the proliferation image data of the target immune cells on each proliferation node is obtained after running the culture environment control scheme, and the nutrient supply content parameters required for culturing the target immune cells are adjusted based on the difference analysis between the actual proliferation texture contrast and the reference proliferation texture contrast of the proliferation image data on adjacent proliferation nodes to generate a culture environment control scheme for the target immune cells throughout the entire cycle, which specifically includes the following steps:
[0033] The culture environment control scheme is run by controlling the immune cell culture device to intelligently control and adjust the culture environment of each proliferation node of the target immune cells. After each proliferation node is controlled and adjusted, a confocal microscope is used to observe and record the proliferation state of the target immune cells on each proliferation node to obtain the proliferation image data of the target immune cells on each proliferation node;
[0034] The GLCM algorithm is introduced to grayscale the proliferation image data on each proliferation node, and after the grayscale quantization, the grayscale level frequency of each pair of pixels in the proliferation image data is calculated, and a matrix is constructed according to the grayscale level frequency to obtain a plurality of grayscale co-occurrence matrices of the proliferation image data;
[0035] Constructing a texture contrast mapping space, mapping and calculating the gray-level co-occurrence matrix between the proliferation image data corresponding to the adjacent proliferation nodes in the texture contrast mapping space based on the node timing of each proliferation node, and obtaining the texture contrast of the gray-level co-occurrence matrix corresponding to the adjacent proliferation nodes, which is defined as the actual proliferation texture contrast;
[0036] Extract the preset nutrient supply content parameters on each proliferation node through the preset culture strategy, and obtain the proliferation rate of the target immune cells under the culture environment parameters after control and adjustment at each proliferation node and the preset nutrient supply content parameters based on the knowledge graph of the immune cell field;
[0037] Establishing a reference grayscale co-occurrence matrix for target immune cell proliferation on each proliferation node according to the proliferation rate, obtaining a texture contrast of the reference grayscale co-occurrence matrix from the current proliferation node to the next proliferation node, which is defined as a reference proliferation texture contrast;
[0038] If the actual proliferation texture contrast is not greater than the reference proliferation texture contrast, the nutrient supply content parameter on the proliferation node corresponding to the actual proliferation texture contrast is marked as a balanced state and the next adjacent proliferation node is judged;
[0039] If the actual proliferation texture contrast is greater than the benchmark proliferation texture contrast, the nutrient supply content parameter on the proliferation node corresponding to the actual proliferation texture contrast is marked as a nutritional imbalance state, and the nutrient supply content parameter on the proliferation node corresponding to the actual proliferation texture contrast is adjusted according to the difference between the actual proliferation texture contrast and the benchmark proliferation texture contrast to generate a nutrient supply control plan for the entire cycle of target immune cells.
[0040] Furthermore, in a preferred embodiment of the present invention, the simulated dynamic stroke control model of different sub-culture devices in the immune cell culture device in the preset culture area is obtained based on the culture environment control scheme and the simulation operation of the culture environment control scheme, and the actual dynamic stroke control model of the current culture node is obtained at the same time. The operation and maintenance calibration of the immune cell culture device is performed according to the model deviation between the actual dynamic stroke control model and the corresponding simulated dynamic stroke control model to obtain the operation and maintenance scheme, which specifically includes the following steps:
[0041] Obtaining a preset culture area of the immune cell culture device, and at the same time obtaining a mechanical structure design drawing and a mechanical activity principle of each sub-culture device in the immune cell culture device, planning a preset movable range of each sub-culture device according to the mechanical structure design drawing and the mechanical activity principle, and dividing the preset culture area into N sub-culture areas based on the preset movable range;
[0042] Upload the target immune cell full-cycle culture environment control scheme and nutrient supply control scheme to the simulation model of the immune cell culture device, and execute the preset culture strategy again to simulate the target immune cell full-cycle culture for the second time;
[0043] During the secondary full-cycle simulated cultivation process, the cultivation activity itinerary and corresponding travel control parameters of each sub-cultivation device in the N sub-cultivation areas are output, and a simulated dynamic travel control model of each sub-cultivation device in different sub-cultivation areas is constructed based on the cultivation activity itinerary and corresponding travel control parameters;
[0044] Obtain the linkage control sequence of the preset cultivation strategy to run the cultivation environment control scheme and the nutrition supply control scheme on the current cultivation node, calculate the cultivation weight value of each sub-cultivation area according to the linkage control sequence, and only mark the sub-cultivation area corresponding to the cultivation weight value greater than the preset cultivation weight value, and define it as the target sub-cultivation area;
[0045] Obtaining an actual dynamic stroke control model for the operation of the sub-cultivation device required for the sub-cultivation area to be determined on the current cultivation node, calculating the Mahalanobis distance between the actual dynamic stroke control model and the corresponding simulated dynamic stroke control model, and determining the model deviation according to the Mahalanobis distance;
[0046] Based on the model deviation, the actual travel control of the sub-culture device in the stator culture area that controls the operation of the culture environment control scheme and the nutrition supply control scheme is calibrated and monitored in real time to obtain an operation and maintenance plan.
[0047] The second aspect of the present invention provides an intelligent control and operation and maintenance system for an immune cell culture device, the intelligent control and operation and maintenance system comprising a memory and a processor, the memory storing an intelligent control and operation and maintenance method program, and when the intelligent control and operation and maintenance method program is executed by the processor, any one of the steps of the intelligent control and operation and maintenance method is implemented.
[0048] The present invention solves the technical defects existing in the background technology, and the beneficial technical effects of the present invention are:
[0049] Through the target immune cell culture model and the physiological characteristic parameters of chemokines, the migration activity is analyzed to obtain a type of active immune cells and a type of active immune cells; based on the type of active immune cells and the type of active immune cells, the control deviation of the culture environment parameter set corresponding to the target immune cells on each proliferation node is analyzed to generate a culture environment control scheme for the full cycle of the target immune cells; after running the culture environment control scheme, the proliferation image data of the target immune cells on each proliferation node is obtained, and the nutritional supply content parameters required for the culture of the target immune cells are adjusted based on the difference analysis of the actual proliferation texture contrast and the benchmark proliferation texture contrast of the proliferation image data on the adjacent proliferation nodes, and the culture environment control scheme for the full cycle of the target immune cells is generated; based on the culture environment control scheme and the simulation operation of the culture environment control scheme, the simulated dynamic stroke control model of different sub-culture devices in the immune cell culture device in the preset culture area is obtained, and the immune cell culture device is calibrated according to the model deviation between the actual dynamic stroke control model and the corresponding simulated dynamic stroke control model. The present invention can more accurately and intelligently control the environmental changes of the immune cell culture device in the process of culturing immune cells in different proliferation growth stages and the accurate supply of culture nutrients, ensure the culture quality of the immune cells by the culture device, and improve the function and survival rate of the immune cells. BRIEF DESCRIPTION OF THE DRAWINGS
[0050] In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the drawings required for use in the embodiments or the description of the prior art will be briefly introduced below. Obviously, the drawings described below are only some embodiments of the present invention. For ordinary technicians in this field, drawings of other embodiments can be obtained based on these drawings without paying creative work.
[0051] Figure 1 A first method flow chart of an intelligent control and operation and maintenance method for an immune cell culture device is shown;
[0052] Figure 2 A second method flow chart of an intelligent control and operation and maintenance method for an immune cell culture device is shown;
[0053] Figure 3 A third method flow chart of an intelligent control and operation and maintenance method of an immune cell culture device is shown;
[0054] Figure 4 A system framework diagram of an intelligent control and operation and maintenance system for an immune cell culture device is shown. DETAILED DESCRIPTION
[0055] In order to more clearly understand the above-mentioned purpose, features and advantages of the present invention, the present invention is further described in detail below in conjunction with the accompanying drawings and specific embodiments. It should be noted that the embodiments of the present application and the features in the embodiments can be combined with each other without conflict.
[0056] In the following description, many specific details are set forth to facilitate a full understanding of the present invention. However, the present invention may also be implemented in other ways different from those described herein. Therefore, the protection scope of the present invention is not limited to the specific embodiments disclosed below.
[0057] The first aspect of the present invention provides an intelligent control and operation method of an immune cell culture device, such as Figure 1 As shown, the following steps are included:
[0058] S102: constructing a simulation model of an immune cell culture device to simulate the culture in a full cycle to obtain a target immune cell culture model at each proliferation node, analyzing the migration activity through the target immune cell culture model and the physiological characteristic parameters of chemokines, and obtaining a type I active immune cell and a type II active immune cell;
[0059] S104: Analyzing the control deviation of the culture environment parameter set corresponding to the target immune cells at each proliferation node based on the first type of active immune cells and the second type of active immune cells, and generating a culture environment control plan for the entire cycle of the target immune cells;
[0060] S106: Obtaining proliferation image data of target immune cells on each proliferation node after running the culture environment control scheme, adjusting the nutrient supply content parameters required for culturing the target immune cells based on the difference analysis between the actual proliferation texture contrast and the reference proliferation texture contrast of the proliferation image data on adjacent proliferation nodes, and generating a culture environment control scheme for the target immune cells throughout the entire cycle;
[0061] S108: Based on the culture environment control scheme and the simulation operation of the culture environment control scheme, the simulated dynamic stroke control models of different sub-culture devices in the immune cell culture device in the preset culture area are obtained, and the actual dynamic stroke control model of the current culture node is obtained. The immune cell culture device is operated and calibrated according to the model deviation between the actual dynamic stroke control model and the corresponding simulated dynamic stroke control model to obtain an operation and maintenance plan.
[0062] Furthermore, in a preferred embodiment of the present invention, the simulation model of the immune cell culture device is constructed to simulate the culture in the whole cycle to obtain the target immune cell culture model at each proliferation node, and the migration activity is analyzed by the target immune cell culture model and the physiological characteristic parameters of the chemokines to obtain the first type of active immune cells and the second type of active immune cells, which specifically includes the following steps:
[0063] Acquire a culture case of target immune cells from a big data network, initialize preset culture parameters of an immune cell culture device based on the culture case, and generate a preset culture strategy for the target immune cells;
[0064] Obtaining the growth cycle law of target immune cells, presetting multiple proliferation nodes of target immune cells based on the growth cycle law, constructing a simulation model of an immune cell culture device, using the simulation model to execute a preset culture strategy to perform full-cycle simulated culture of target immune cells, and extracting target immune cell culture models at various proliferation nodes during the full-cycle simulated culture process;
[0065] Obtain the type information of the target immune cells, and at the same time obtain the knowledge graph of the immune cell field based on the big data network, import the type information into the knowledge graph of the immune cell field for identification, and output the chemokines that can act on the target immune cells and multiple physiological characteristic parameters corresponding to each chemokine;
[0066] Acquire the culture environment parameters of the simulation model when executing the preset culture strategy at each proliferation node, introduce the particle swarm optimization algorithm to calculate the particle fitness function and the optimal position of the culture environment parameters and multiple physiological characteristic parameters corresponding to each chemokine, and obtain the particle fitness and the global optimal position;
[0067] Continuously updating and iterating the fitness of the current particle according to the global optimal position, obtaining the current iteration value, judging whether the current iteration value reaches a preset iteration threshold, and if so, outputting the final fitness of each particle, and constructing a chemokine signal release model for different proliferation culture environments according to the final fitness;
[0068] The chemokine signal release model is used to determine and analyze the migration activity of the target immune cell culture model at each proliferation node in response to the target chemokine, thereby obtaining a type I active immune cell and a type II active immune cell.
[0069] It should be noted that, since immune cells undergo different proliferation and growth stages during the proliferation and culture process, and the culture environment conditions and nutritional conditions required for immune cells at different proliferation and growth stages are different, if the immune cell culture device fails to intelligently control these condition parameters according to the growth stage of immune cell culture in time, there will be a phenomenon of uneven culture activity at different proliferation and growth stages using unified culture parameters. For example, the environmental parameters in the initial proliferation stage are suitable for immune cell proliferation, but these environmental parameters cannot make immune cells proliferate better when entering the next proliferation stage, which may cause the activity presented by immune cells at different proliferation and growth stages to fluctuate, reducing the activity quality and survival rate of immune cells. Therefore, it is first necessary to accurately determine whether the culture environment parameters of immune cells at each proliferation and growth stage will affect the proliferation activity of immune cells, so that the proliferation activity of immune cells at each proliferation and growth stage can be improved by regulating the culture environment parameters with abnormal control deviations; in order to understand the cell activity at different proliferation and growth stages, the traditional immune cell culture method needs to manually extract the immune cells in culture and test their therapeutic quality for the target treatment object chemokine, which increases the labor cost. Therefore, this method constructs a chemokine signal release model for different proliferation culture environments by combining the culture environment parameters of each proliferation node with multiple physiological characteristic parameters of chemokines. This model can simulate the chemokine environment of the test subject for the desired treatment. By performing receptor binding simulation analysis on immune cells at different proliferation and growth stages in this model, the activity quality of immune cells at different proliferation and growth stages can be quickly and accurately analyzed, replacing the tedious steps of traditional manual extraction testing, saving time and effort, and at the same time displaying the culture quality of immune cells by the immune cell culture device in real time, significantly improving the accuracy and reliability of the control of immune cell environmental parameters.
[0070] It should be noted that the preset culture strategy is a culture plan formulated for target immune cells based on a series of culture parameters provided by the culture case, such as when to increase the air pressure, how to increase the air pressure, and how much to increase the air pressure. Culture environment parameters include temperature, humidity, air pressure, carbon dioxide concentration, oxygen concentration, and pH value. Chemokines include toxins produced by bacteria, signal molecules released by damaged tissues, and cytokines secreted by cells. Physiological characteristic parameters include molecular weight, amino acid sequence, and receptor binding. The particle swarm algorithm can accurately optimize and adjust the model parameters according to the global relationship between the culture environment and the physiological characteristics of different chemokines. If the current iteration value does not reach the preset iteration threshold, the iteration will continue to be updated until the preset iteration threshold position is reached to ensure that the chemokine signal release model is close to the actual test scenario and environment, and improve the positioning accuracy of the immune cell culture quality.
[0071] Furthermore, in a preferred embodiment of the present invention, the chemokine signal release model is used to determine and analyze the migration activity of the target immune cell culture model at each proliferation node in response to the target chemokine, and a type I active immune cell and a type II active immune cell are obtained, such as Figure 2 As shown, the specific steps include:
[0072] S202: Preset a signal release frequency threshold and an ideal active migration duration of the target chemokine, and plan a signal release response range of the target chemokine based on the signal release frequency threshold;
[0073] S204: embedding the target immune cell culture model at each proliferation node into the corresponding proliferation node of the chemokine signal release model to perform migration analysis of the ideal active migration time, and extracting the migration path of the target immune cells in different proliferation culture environments in response to the target chemokine signal at the ideal active migration time;
[0074] S206: detecting the target immune cells on each proliferation node by a confocal microscope to draw a surface receptor distribution map of the target immune cells on each proliferation node, and planning the receptor sensing range of the target immune cells on each proliferation node that can respond to and bind to the target chemokine based on the surface receptor distribution map;
[0075] S208: Obtaining the migration endpoint of the target immune cell under different proliferation environments based on the migration path, determining whether the receptor perception range and the signal release response range intersect when the target immune cell reaches the migration endpoint; if so, it indicates that the target immune cell can bind to the target chemokine within the ideal active migration time, and the target immune cell is marked as a type of active immune cell;
[0076] S210: If not present, it indicates that the target immune cell cannot bind to the target chemokine within the ideal active migration time, and the target immune cell is labeled as a Class II active immune cell.
[0077] It should be noted that since chemokines produce some chemical stimulation signals and there are special receptors on the surface of immune cells, the surface receptors of immune cells can migrate along the chemical gradient of chemokines under the guidance of these chemical stimulation signals, so that they can recognize and bind to the chemokine transmission signals to execute the treatment mechanism. However, if the immune cells fail to migrate to the location of the chemokines or the migration rate is slow, it means that the activity of the immune cells is low and they do not have the ability to efficiently bind to the chemokines. Therefore, it is necessary to analyze the migration ability of immune cells on different proliferation nodes in the chemokine signal release model. Since chemokines can produce specific chemical stimulation signals to guide immune cells, this method sets a signal release response range in the chemokine signal release model to respond to the actual migration of the immune cell model; and the receptor distribution on the surface of immune cells can sense these signals so as to quickly locate the specific position of chemokines. Therefore, this method also sets a receptor perception range that can respond to these stimulation signals to respond to the target chemokine. In the chemokine signal release model, it is analyzed whether the immune cell model can respond to the stimulation signal of the target chemokine after migrating within the ideal migration time, that is, whether the receptor perception range of the target immune cell reaches the migration end point. Whether there is an intersection with the signal release response range, if so, it means that the target immune cell can bind to the target chemokine within the ideal active migration time, proving that the immune cell activity of the proliferation node is high, if not, it proves that the immune cell activity of the proliferation node is low, thereby further accurately determining the migration activity quality of the immune cells corresponding to each proliferation growth node. Therefore, this method can optimize environmental parameters according to the uneven quality of immune cell migration activity, provide a feasibility analysis basis for the intelligent control of subsequent culture environment parameters, and effectively improve the intelligence and accuracy of the culture environment control of the immune cell culture device.
[0078] Further, in a preferred embodiment of the present invention, the control deviation of the culture environment parameter set corresponding to the target immune cells on each proliferation node is analyzed based on the first type of active immune cells and the second type of active immune cells to generate a culture environment control scheme for the entire cycle of the target immune cells, which specifically includes the following steps:
[0079] When the target immune cell on the proliferation node is a type of active immune cell, the intersection space model region between the receptor sensing range and the signal release response range of the target chemokine when the target immune cell reaches the migration end point is obtained;
[0080] Constructing a multidimensional space geometric topology field, performing geometric interpolation of multiple groups of preset control points on the intersection space model area in the multidimensional space geometric topology field to obtain a plurality of regional interpolations, and calculating the volume of the intersection space model area through the plurality of regional interpolation topologies to obtain a volume value of the intersection space model area;
[0081] Preset an ideal active migration path of the target immune cells, and obtain a standard intersection space model area volume value of a receptor perception range and a signal release response range when the target immune cells reach the ideal active migration path;
[0082] Calculate the difference between the volume value of the intersection space model area and the volume value of the standard intersection space model area to obtain a volume deviation value, and regulate the culture environment parameter set on the proliferation node corresponding to a type of active immune cells according to the volume deviation value to obtain a first culture environment regulation parameter set;
[0083] When the target immune cell on the proliferation node is a type II active immune cell, the migration path of the type II active immune cell in response to the target chemokine signal during the ideal active migration duration is obtained, and multiple uniform path segmentation points are preset;
[0084] Introducing a linear least squares method to calculate and fit a linear least squares model of the migration path and an ideal active migration path, calculating the sum of square errors at each uniform path segmentation point in the linear least squares model, and determining the path drift amplitude of the migration path compared to the ideal active migration path according to the sum of square errors of the path;
[0085] According to the path drift amplitude, a culture environment parameter set on the proliferation node corresponding to the second type of active immune cells is regulated to obtain a second culture environment regulation parameter set;
[0086] The node timing of each proliferation node is obtained based on the growth cycle law, and the first culture environment control parameter set and the second culture environment control parameter set on each proliferation node are spliced in time based on the node timing to generate a culture environment control plan for the entire cycle of target immune cells.
[0087] It should be noted that traditional control methods for immune cell culture devices usually make it difficult to achieve targeted and precise regulation of the culture environment parameters required for each proliferation and growth stage based on the proliferation activity and quality of immune cells, resulting in a significant decrease in the proliferation rate and quality of immune cells. At the same time, traditional methods require manual intervention to regulate environmental parameters, which slows the culture progress and reduces the culture efficiency. When the immune cells cultured on a certain proliferation node of the immune cell culture device are a type of active immune cells, it means that the culture environment parameters on this proliferation node are more suitable for immune cell culture. However, according to the migration status of the immune cell model corresponding to this proliferation node in the chemokine signal release model, there may still be a certain control deviation, which makes it impossible to achieve the optimal ideal migration state. Therefore, this method analyzes the intersection of the receptor perception range of a type of active immune cells and the signal release response range of the target chemokine based on the chemokine signal release model, and interpolates the topology in the multidimensional space geometric topology field and calculates the volume deviation value between the two. The volume deviation value intuitively reflects the space that can be optimized and improved for the culture environment parameters corresponding to a type of active immune cells compared with the culture environment parameters required for standard migration activity, so that the environmental parameters for culturing a type of active immune cells can be further optimized according to the volume deviation value, so that the culture accuracy of the immune cell culture device can be better improved when the culture activity is qualified. When the immune cells cultured by the immune cell culture device at a certain proliferation node are Class II active immune cells, it means that there are serious errors in the culture environment parameters at this proliferation node, which leads to a reduction in the proliferation activity of the immune cells. Therefore, this method can optimize the culture environment parameters by analyzing the drift amplitude of the migration path of the immune cell model compared to the ideal migration path. Since the proliferation and growth of immune cells have a certain time continuity, it is necessary to splice all the adjusted culture environment parameters in a time sequence, so that the immune cell culture device can control the environment parameters more logically and accurately, avoid the occurrence of control timing disorder that affects the quality of immune cell culture, and have high reliability.
[0088] Furthermore, in a preferred embodiment of the present invention, the proliferation image data of the target immune cells on each proliferation node is obtained after running the culture environment control scheme, and the nutrient supply content parameters required for culturing the target immune cells are adjusted based on the difference analysis between the actual proliferation texture contrast and the reference proliferation texture contrast of the proliferation image data on adjacent proliferation nodes to generate a culture environment control scheme for the target immune cells throughout the entire cycle, which specifically includes the following steps:
[0089] The culture environment control scheme is run by controlling the immune cell culture device to intelligently control and adjust the culture environment of each proliferation node of the target immune cells. After each proliferation node is controlled and adjusted, a confocal microscope is used to observe and record the proliferation state of the target immune cells on each proliferation node to obtain the proliferation image data of the target immune cells on each proliferation node;
[0090] The GLCM algorithm is introduced to grayscale the proliferation image data on each proliferation node, and after the grayscale quantization, the grayscale level frequency of each pair of pixels in the proliferation image data is calculated, and a matrix is constructed according to the grayscale level frequency to obtain a plurality of grayscale co-occurrence matrices of the proliferation image data;
[0091] Constructing a texture contrast mapping space, mapping and calculating the gray-level co-occurrence matrix between the proliferation image data corresponding to the adjacent proliferation nodes in the texture contrast mapping space based on the node timing of each proliferation node, and obtaining the texture contrast of the gray-level co-occurrence matrix corresponding to the adjacent proliferation nodes, which is defined as the actual proliferation texture contrast;
[0092] Extract the preset nutrient supply content parameters on each proliferation node through the preset culture strategy, and obtain the proliferation rate of the target immune cells under the culture environment parameters after control and adjustment at each proliferation node and the preset nutrient supply content parameters based on the knowledge graph of the immune cell field;
[0093] Establishing a reference grayscale co-occurrence matrix for target immune cell proliferation on each proliferation node according to the proliferation rate, obtaining a texture contrast of the reference grayscale co-occurrence matrix from the current proliferation node to the next proliferation node, which is defined as a reference proliferation texture contrast;
[0094] If the actual proliferation texture contrast is not greater than the reference proliferation texture contrast, the nutrient supply content parameter on the proliferation node corresponding to the actual proliferation texture contrast is marked as a balanced state and the next adjacent proliferation node is judged;
[0095] If the actual proliferation texture contrast is greater than the benchmark proliferation texture contrast, the nutrient supply content parameter on the proliferation node corresponding to the actual proliferation texture contrast is marked as a nutritional imbalance state, and the nutrient supply content parameter on the proliferation node corresponding to the actual proliferation texture contrast is adjusted according to the difference between the actual proliferation texture contrast and the benchmark proliferation texture contrast to generate a nutrient supply control plan for the entire cycle of target immune cells.
[0096] It should be noted that the immune cell culture device not only needs to control the culture environment, but also provides appropriate nutrients for immune cells according to the culture requirements. For example, immune cells consume nutrients such as glucose or growth factors during the culture process, and nutritional supplements are required after they are completely consumed. However, the traditional culture device has defects in the ability to judge the supply of nutrients, which leads to control deviations when controlling the supply of nutrients, and then the culture medium provides insufficient or excessive nutrients for immune cells. The inappropriate nutrients affect the quality of the culture and proliferation of immune cells, and may even cause the death of immune cells, reducing the survival rate. Therefore, when controlling the supply of nutrients, it is necessary to analyze the immune cell proliferation culture conditions at each proliferation node. The most significant proliferation of immune cells is the growth of the number of cells to form a certain cell density, but too dense a cell density will also affect the growth of immune cells. Therefore, the amount of nutrient supply and the control parameters required can be accurately optimized by controlling the cell density of immune cells. This method can compare whether the actual cell proliferation texture displayed in the proliferation image data meets the benchmark proliferation texture, and whether the actual cell proliferation density tends to a normal level can be known by comparing the two. For the comparison between the two, the cell proliferation features of the proliferation image data, that is, the grayscale co-occurrence matrix of the cell proliferation texture, are extracted, and then the contrast of the grayscale co-occurrence matrix is mapped out through the texture contrast mapping space. The contrast can measure the degree of difference between textures in the grayscale co-occurrence matrix. If the actual proliferation texture contrast is greater than the baseline proliferation texture contrast, it means that the texture is uniform, and the actual immune cell proliferation is in a nutritionally balanced state, so there is no need to supplement additional nutrients to avoid overnutrition; otherwise, the more uneven the texture is, the more likely it is that the actual immune cell proliferation is in an unbalanced state of malnutrition, which makes the proliferation density too low or too high, and the immune cells need to be supplemented with nutrients.
[0097] In summary, this method can achieve the effect of precise and intelligent control of nutrient supply by the immune cell culture device, thereby ensuring the quality of nutrient output of the immune cell culture device during the process of culturing immune cells, ensuring the rationality and reliability of nutrient supply supplementation, avoiding the occurrence of nutrient deficiency or excess that affects the quality of immune cell proliferation and living environment, and improving the survival rate of immune cell culture. Among them, the Chinese name of the GLCM algorithm is the grayscale co-occurrence matrix algorithm, which is used to describe the texture features of the image by counting the symbiosis of gray levels in the image. The GLCM algorithm can capture texture information of different scales in the image at multiple scales, improve the robustness of feature extraction of proliferation image data, and make the immune cell proliferation texture more accurate and clear.
[0098] Furthermore, in a preferred embodiment of the present invention, the simulated dynamic stroke control model of different sub-culture devices in the immune cell culture device in the preset culture area is obtained based on the culture environment control scheme and the simulation operation of the culture environment control scheme, and the actual dynamic stroke control model of the current culture node is obtained at the same time. The immune cell culture device is operated and calibrated according to the model deviation between the actual dynamic stroke control model and the corresponding simulated dynamic stroke control model to obtain an operation and maintenance scheme, such as Figure 3 As shown, the specific steps include:
[0099] S302: obtaining a preset culture area of the immune cell culture device, and simultaneously obtaining a mechanical structure design drawing and a mechanical activity principle of each sub-culture device in the immune cell culture device, planning a preset movable range of each sub-culture device according to the mechanical structure design drawing and the mechanical activity principle, and dividing the preset culture area into N sub-culture areas based on the preset movable range;
[0100] S304: uploading the culture environment control scheme and the nutrient supply control scheme of the target immune cells throughout the entire cycle to the simulation model of the immune cell culture device, and executing the preset culture strategy again to simulate the culture of the target immune cells throughout the entire cycle for the second time;
[0101] S306: During the secondary full-cycle simulated cultivation process, the cultivation activity itinerary and corresponding travel control parameters of each sub-cultivating device in the N sub-cultivating areas are output, and a simulated dynamic travel control model of each sub-cultivating device in different sub-cultivating areas is constructed based on the cultivation activity itinerary and corresponding travel control parameters;
[0102] S308: Obtaining the linkage control sequence of the preset cultivation strategy to run the cultivation environment control scheme and the nutrition supply control scheme on the current cultivation node, calculating the cultivation weight value of each sub-cultivation area according to the linkage control sequence, and marking only the sub-cultivation area corresponding to the cultivation weight value greater than the preset cultivation weight value, and defining them as the target sub-cultivation area;
[0103] S310: obtaining an actual dynamic stroke control model for the operation of the sub-cultivation device required for the sub-cultivation area to be determined on the current cultivation node, calculating the Mahalanobis distance between the actual dynamic stroke control model and the corresponding simulated dynamic stroke control model, and determining the model deviation according to the Mahalanobis distance;
[0104] S312: Based on the model deviation, an actual travel control of the sub-cultivation device in the stator sub-cultivation area that controls the operation of the cultivation environment control scheme and the nutrition supply control scheme is calibrated and monitored in real time to obtain an operation and maintenance plan.
[0105] It should be noted that the immune cell culture device is usually composed of a plurality of culture devices, such as a culture medium oscillation device, a nutrient injection device, a local temperature control device, and an automated robotic arm and other sub-culture devices. If the above-mentioned sub-culture devices are in continuous operation for a long time or are not regularly adjusted, it may cause serious errors when each sub-culture device performs its respective predetermined culture function. For example, when there is an error in the nutrient injection device, the nutrient injection action and dosage control of the immune cells deviate from the normal standards, resulting in a decrease in the activity of the immune cell culture and a significant increase in the cell mortality rate. Since different sub-cultivation equipment is limited by its own activity range and cultivation function, each sub-cultivation equipment corresponds to a different activity area in the preset cultivation area. Therefore, this method can first obtain the simulated dynamic stroke control model of each sub-cultivation device in different sub-cultivation areas by simulating in the simulation model, and then obtain the actual dynamic stroke control model of the sub-cultivation device corresponding to the sub-cultivation area that needs to be cultivated on the current cultivation node, and compare and calculate the model deviation between the two. This model deviation represents the difference between the actual cultivation activity stroke of the sub-cultivation device in the current immune cell cultivation device and the cultivation activity stroke required when the sub-cultivation device runs the cultivation environment control scheme and the nutrition supply control scheme. Therefore, it is necessary to perform operation and maintenance calibration and real-time monitoring on the cultivation activity stroke difference reflected by this model deviation, so as to repair the unreasonable control behavior errors of each sub-cultivation device during the operation of the immune cell cultivation device, optimize the cultivation quality and efficiency of the immune cell cultivation device for immune cells, and improve the cultivation activity and survival rate of immune cells.
[0106] It should be noted that the linkage control sequence is the sequence in which a certain control parameter needs to maintain control linkage with a certain nutrient control parameter of the nutrient supply control scheme when the preset culture strategy runs the culture environment control scheme. The linkage control sequence can express the control requirements of each sub-culture device for different sub-culture areas, and provide accurate positioning basis for real-time monitoring of the control behavior of the sub-culture device and real-time operation and maintenance optimization.
[0107] In addition, the intelligent control and operation and maintenance method of the immune cell culture device further includes the following steps:
[0108] Obtaining the culture control frequency of the immune cell culture device and the proliferation rate of the target immune cells. When the culture control frequency is greater than the preset culture control frequency and the proliferation rate is lower than the preset proliferation rate, obtaining the historical control data source corresponding to each culture control frequency and the historical control data source corresponding to each proliferation rate and performing corresponding data bundling processing to generate multiple culture abnormality data packets;
[0109] Acquire the maximum stroke control characteristic parameters of each sub-culture device in the immune cell culture device, introduce the Spearson correlation coefficient to calculate the correlation between each culture abnormality data packet and the maximum stroke control characteristic parameters of each sub-culture device, and obtain multiple correlations;
[0110] Determine the control abnormality correlation degree of each sub-cultivation device that causes the abnormal cultivation data packet according to the correlation degree, extract the sub-cultivation device corresponding to the control abnormality correlation degree greater than the preset control abnormality correlation degree, and mark it as a suspicious sub-cultivation device;
[0111] Acquire the actual culture control variables of each suspicious sub-culture device within a preset time period, introduce the maximum likelihood algorithm to perform maximum likelihood estimation on the actual control variables of each suspicious sub-culture device within the preset time period, and obtain the probability of control abnormality of each suspicious sub-culture device;
[0112] If the probability of control abnormality in each suspicious sub-culture device is greater than the preset control abnormality probability, the suspicious sub-culture device is marked as a faulty device point, and the faulty device point is uploaded and recorded in the operation and maintenance log of the immune cell culture device.
[0113] It should be noted that the maximum control characteristic parameters include maximum stroke control parameters, maximum stroke rate control parameters and maximum stroke time control parameters. When each sub-culture device is in long-term operation, improper operation or not regularly maintained, it will cause different degrees of failure, and the failure of a sub-culture device may cause the entire immune cell culture device to be paralyzed or unable to perform the normal culture process, so that the final cultured immune cells will have large errors in function and therapeutic effect, greatly affecting the culture quality and efficiency of immune cells. This method can determine the sub-culture device that may be suspected of failure by analyzing the correlation between the historical abnormal data output by the immune cell culture device and the operation control characteristics of each sub-culture device, and finally further determine the probability of control abnormality of the suspicious sub-culture device in the maximum likelihood algorithm. If the probability of control abnormality of the suspicious sub-culture device is greater than the preset control abnormality probability, it means that the sub-culture device is the cause of the abnormal culture data of the immune cell culture device, and maintenance needs to be performed on the suspicious sub-culture device. This method can trace the fault point that causes abnormal culture data in the immune cell culture device, thereby facilitating operation and maintenance personnel to quickly locate and formulate a maintenance plan, optimizing the operation and maintenance efficiency of the immune cell culture device and effectively increasing the service life of the device.
[0114] In addition, the intelligent control and operation and maintenance method of the immune cell culture device further includes the following steps:
[0115] Acquire a culture log of an immune cell culture device, and extract a culture medium metabolic index of the immune cell culture device at different preset proliferation nodes based on the culture log to obtain a plurality of culture medium metabolic indexes;
[0116] Calculating the survival rate of the target immune cells cultured by the immune cell culture device at the proliferation node according to the multiple culture medium metabolic indices, and if the survival rate is lower than the preset survival rate, obtaining the actual culture deviation rate of the target immune cells cultured by the immune cell culture device;
[0117] Obtaining control parameters corresponding to each sub-culture device in the immune cell culture device under different preset culture deviation rates through a big data network, and calculating the gray correlation degree between the actual culture deviation rate and different preset culture deviation rates through a gray correlation analysis method to obtain multiple gray correlation degrees;
[0118] Extracting a preset culture deviation rate corresponding to a maximum grey correlation degree from a plurality of grey correlation degrees, and determining actual control parameters corresponding to each sub-culture device of the immune cell culture device under an actual culture deviation rate according to the preset culture deviation rate corresponding to the maximum grey correlation degree;
[0119] Obtaining the ideal control parameters of each sub-cultivation device, and calculating the error value between the actual control parameters corresponding to each sub-cultivation device and the reference control parameters corresponding to each sub-cultivation device, to obtain the error value of each sub-cultivation device;
[0120] If the error value is greater than the preset error value, the sub-culture device is marked as a sub-culture device to be optimized, and the actual control parameters and culture decisions of the sub-culture device are adjusted and optimized based on the error value, and finally uploaded to the control terminal of the immune cell culture device.
[0121] It should be noted that the culture medium is one of the key tools for culturing immune cells. The immune cell culture device usually needs to rely on and adjust the culture medium environment to improve the culture quality of immune cells. During the proliferation of immune cells, a variety of nutrient components in the culture medium will be consumed, and metabolites will be produced in the culture medium. Therefore, the survival rate of immune cells can be calculated based on the culture metabolic index analysis. When the survival rate is lower than the preset survival rate, it means that a certain sub-culture device link of the immune cell culture device has a deviation in the control of the culture of immune cells, which makes the abnormal proliferation of immune cells and causes the phenomenon of decreased survival rate of immune cells. Therefore, this method can analyze the actual control parameters corresponding to each sub-culture device of the immune cell culture device under the actual culture deviation rate according to the phenomenon of immune cell survival rate, and adjust and calibrate the actual control parameters according to the ideal control parameters of each sub-culture device, so as to accurately and pointwise optimize the actual control parameters and culture decisions of the sub-culture device with control deviation in the immune cell culture device, repair the culture deviation of the immune cell culture device, and improve the culture survival rate of immune cells, with high economic benefits.
[0122] The second aspect of the present invention provides an intelligent control and operation and maintenance system for an immune cell culture device, such as Figure 4 As shown, the intelligent control and operation and maintenance system includes a memory 41 and a processor 42. The memory 41 stores an intelligent control and operation and maintenance method program. When the intelligent control and operation and maintenance method program is executed by the processor 42, any one of the steps of the intelligent control and operation and maintenance method is implemented.
[0123] The above are only specific embodiments of the present invention, but the protection scope of the present invention is not limited thereto. Any person skilled in the art who is familiar with the technical field can easily think of changes or substitutions within the technical scope disclosed by the present invention, which should be included in the protection scope of the present invention. Therefore, the protection scope of the present invention should be based on the protection scope of the claims.
Claims
1. An intelligent control and operation and maintenance method for an immune cell culture device, characterized in that: The following steps are involved: Construct a simulation model of an immune cell culture device to simulate the culture in the whole cycle to obtain a target immune cell culture model at each proliferation node, analyze the migration activity through the target immune cell culture model and the physiological characteristic parameters of chemokines, and obtain a type I active immune cell and a type II active immune cell; Analyze the control deviation of the culture environment parameter set corresponding to the target immune cells at each proliferation node based on the first type of active immune cells and the second type of active immune cells, and generate a culture environment control plan for the entire cycle of the target immune cells; Obtaining proliferation image data of target immune cells on each proliferation node after running the culture environment control scheme, adjusting the nutrient supply content parameters required for culturing target immune cells based on the difference analysis between the actual proliferation texture contrast and the reference proliferation texture contrast of the proliferation image data on adjacent proliferation nodes, and generating a nutrient supply control scheme for the full cycle of target immune cells; Based on the simulation operation of the culture environment control scheme and the nutrient supply control scheme, a simulated dynamic travel control model of different sub-culture devices in the immune cell culture device in a preset culture area is obtained, and at the same time, an actual dynamic travel control model of the current culture node is obtained, and the immune cell culture device is operated and calibrated according to the model deviation between the actual dynamic travel control model and the corresponding simulated dynamic travel control model to obtain an operation and maintenance scheme; Among them, constructing a simulation model of an immune cell culture device to simulate the culture in the whole cycle to obtain a target immune cell culture model at each proliferation node, analyzing the migration activity through the target immune cell culture model and the physiological characteristic parameters of chemokines, and obtaining a type I active immune cell and a type II active immune cell, specifically includes the following steps: Acquire a culture case of target immune cells from a big data network, initialize preset culture parameters of an immune cell culture device based on the culture case, and generate a preset culture strategy for the target immune cells; Obtaining the growth cycle law of target immune cells, presetting multiple proliferation nodes of target immune cells based on the growth cycle law, constructing a simulation model of an immune cell culture device, using the simulation model to execute a preset culture strategy to perform full-cycle simulated culture of target immune cells, and extracting target immune cell culture models at various proliferation nodes during the full-cycle simulated culture process; Obtain the type information of the target immune cells, and at the same time obtain the knowledge graph of the immune cell field based on the big data network, import the type information into the knowledge graph of the immune cell field for identification, and output the chemokines that can act on the target immune cells and multiple physiological characteristic parameters corresponding to each chemokine; Acquire the culture environment parameters of the simulation model when executing the preset culture strategy at each proliferation node, introduce the particle swarm optimization algorithm to calculate the particle fitness function and the optimal position of the culture environment parameters and multiple physiological characteristic parameters corresponding to each chemokine, and obtain the particle fitness and the global optimal position; Continuously updating and iterating the fitness of the current particle according to the global optimal position, obtaining the current iteration value, judging whether the current iteration value reaches a preset iteration threshold, and if so, outputting the final fitness of each particle, and constructing a chemokine signal release model for different proliferation culture environments according to the final fitness; The chemokine signal release model is used to determine and analyze the migration activity of the target immune cell culture model at each proliferation node in response to the target chemokine, thereby obtaining a type I active immune cell and a type II active immune cell; The chemokine signal release model is used to determine and analyze the migration activity of the target immune cell culture model at each proliferation node in response to the target chemokine to obtain a type I active immune cell and a type II active immune cell, which specifically includes the following steps: Preset a signal release frequency threshold and an ideal active migration duration of a target chemokine, and plan a signal release response range of the target chemokine based on the signal release frequency threshold; The target immune cell culture model at each proliferation node is embedded in the corresponding proliferation node of the chemokine signal release model to perform migration analysis of the ideal active migration time, and the migration path of the target immune cells in different proliferation culture environments in response to the target chemokine signal at the ideal active migration time is extracted; Detecting target immune cells on each proliferation node by confocal microscopy to draw a surface receptor distribution map of the target immune cells on each proliferation node, and planning the receptor perception range of the target immune cells on each proliferation node that can respond to and bind to the target chemokine based on the surface receptor distribution map; Based on the migration path, the migration endpoint of the target immune cell under different proliferation environments is obtained, and it is determined whether the receptor perception range and the signal release response range intersect when the target immune cell reaches the migration endpoint. If so, it means that the target immune cell can bind to the target chemokine within the ideal active migration time, and the target immune cell is marked as a type of active immune cell; If it does not exist, it means that the target immune cell cannot bind to the target chemokine within the ideal active migration time, and the target immune cell is labeled as a type II active immune cell; Among them, based on the first type of active immune cells and the second type of active immune cells, the control deviation of the culture environment parameter set corresponding to the target immune cells at each proliferation node is analyzed to generate a culture environment control plan for the entire cycle of the target immune cells, which specifically includes the following steps: When the target immune cell on the proliferation node is a type of active immune cell, the intersection space model region between the receptor sensing range and the signal release response range of the target chemokine when the target immune cell reaches the migration end point is obtained; Constructing a multidimensional space geometric topology field, performing geometric interpolation of multiple groups of preset control points on the intersection space model area in the multidimensional space geometric topology field to obtain a plurality of regional interpolations, and calculating the volume of the intersection space model area through the plurality of regional interpolation topologies to obtain a volume value of the intersection space model area; Preset an ideal active migration path of the target immune cells, and obtain a standard intersection space model area volume value of a receptor perception range and a signal release response range when the target immune cells reach the ideal active migration path; Calculate the difference between the volume value of the intersection space model area and the volume value of the standard intersection space model area to obtain a volume deviation value, and regulate the culture environment parameter set on the proliferation node corresponding to a type of active immune cells according to the volume deviation value to obtain a first culture environment regulation parameter set; When the target immune cell on the proliferation node is a type II active immune cell, the migration path of the type II active immune cell in response to the target chemokine signal during the ideal active migration duration is obtained, and multiple uniform path segmentation points are preset; Introducing a linear least squares method to calculate and fit a linear least squares model of the migration path and an ideal active migration path, calculating the sum of square errors at each uniform path segmentation point in the linear least squares model, and determining the path drift amplitude of the migration path compared to the ideal active migration path according to the sum of square errors of the path; According to the path drift amplitude, a culture environment parameter set on the proliferation node corresponding to the second type of active immune cells is regulated to obtain a second culture environment regulation parameter set; Obtaining the node timing of each proliferation node based on the growth cycle law, and performing time-series splicing of the first culture environment control parameter set and the second culture environment control parameter set on each proliferation node based on the node timing, to generate a culture environment control scheme for the entire cycle of the target immune cells; Among them, by running the culture environment control scheme, the proliferation image data of the target immune cells on each proliferation node is obtained, and the nutrient supply content parameters required for culturing the target immune cells are adjusted based on the difference analysis between the actual proliferation texture contrast and the reference proliferation texture contrast of the proliferation image data on adjacent proliferation nodes, so as to generate a nutrient supply control scheme for the target immune cells throughout the whole cycle, which specifically includes the following steps: The culture environment control scheme is run by controlling the immune cell culture device to intelligently control and adjust the culture environment of each proliferation node of the target immune cells. After each proliferation node is controlled and adjusted, a confocal microscope is used to observe and record the proliferation state of the target immune cells on each proliferation node to obtain the proliferation image data of the target immune cells on each proliferation node; The GLCM algorithm is introduced to grayscale the proliferation image data on each proliferation node, and after the grayscale quantization, the grayscale level frequency of each pair of pixels in the proliferation image data is calculated, and a matrix is constructed according to the grayscale level frequency to obtain a plurality of grayscale co-occurrence matrices of the proliferation image data; Constructing a texture contrast mapping space, mapping and calculating the gray-level co-occurrence matrix between the proliferation image data corresponding to the adjacent proliferation nodes in the texture contrast mapping space based on the node timing of each proliferation node, and obtaining the texture contrast of the gray-level co-occurrence matrix corresponding to the adjacent proliferation nodes, which is defined as the actual proliferation texture contrast; Extract the preset nutrient supply content parameters on each proliferation node through the preset culture strategy, and obtain the proliferation rate of the target immune cells under the culture environment parameters after control and adjustment at each proliferation node and the preset nutrient supply content parameters based on the knowledge graph of the immune cell field; Establishing a reference grayscale co-occurrence matrix for target immune cell proliferation on each proliferation node according to the proliferation rate, obtaining a texture contrast of the reference grayscale co-occurrence matrix from the current proliferation node to the next proliferation node, which is defined as a reference proliferation texture contrast; If the actual proliferation texture contrast is not greater than the reference proliferation texture contrast, the nutrient supply content parameter on the proliferation node corresponding to the actual proliferation texture contrast is marked as a balanced state and the next adjacent proliferation node is judged; If the actual proliferation texture contrast is greater than the reference proliferation texture contrast, the nutrient supply content parameter on the proliferation node corresponding to the actual proliferation texture contrast is marked as a nutritional imbalance state, and the nutrient supply content parameter on the proliferation node corresponding to the actual proliferation texture contrast is adjusted according to the difference between the actual proliferation texture contrast and the reference proliferation texture contrast, to generate a nutrient supply control plan for the entire cycle of the target immune cells; Among them, based on the simulation operation of the culture environment control scheme and the nutrient supply control scheme, the simulated dynamic stroke control model of different sub-culture devices in the immune cell culture device in the preset culture area is obtained, and the actual dynamic stroke control model of the current culture node is obtained at the same time. The immune cell culture device is operated and calibrated according to the model deviation between the actual dynamic stroke control model and the corresponding simulated dynamic stroke control model to obtain the operation and maintenance scheme, which specifically includes the following steps: Obtaining a preset culture area of the immune cell culture device, and at the same time obtaining a mechanical structure design drawing and a mechanical activity principle of each sub-culture device in the immune cell culture device, planning a preset movable range of each sub-culture device according to the mechanical structure design drawing and the mechanical activity principle, and dividing the preset culture area into N sub-culture areas based on the preset movable range; Upload the target immune cell full-cycle culture environment control scheme and nutrient supply control scheme to the simulation model of the immune cell culture device, and execute the preset culture strategy again to simulate the target immune cell full-cycle culture for the second time; During the secondary full-cycle simulated cultivation process, the cultivation activity itinerary and corresponding travel control parameters of each sub-cultivation device in the N sub-cultivation areas are output, and a simulated dynamic travel control model of each sub-cultivation device in different sub-cultivation areas is constructed based on the cultivation activity itinerary and corresponding travel control parameters; Obtain the linkage control sequence of the preset cultivation strategy to run the cultivation environment control scheme and the nutrition supply control scheme on the current cultivation node, calculate the cultivation weight value of each sub-cultivation area according to the linkage control sequence, and only mark the sub-cultivation area corresponding to the cultivation weight value greater than the preset cultivation weight value, and define it as the target sub-cultivation area; Obtaining an actual dynamic stroke control model for the operation of the sub-cultivation device required for the sub-cultivation area to be determined on the current cultivation node, calculating the Mahalanobis distance between the actual dynamic stroke control model and the corresponding simulated dynamic stroke control model, and determining the model deviation according to the Mahalanobis distance; Based on the model deviation, the actual travel control of the sub-culture device in the stator culture area that controls the operation of the culture environment control scheme and the nutrition supply control scheme is calibrated and monitored in real time to obtain an operation and maintenance plan.
2. An intelligent control and operation and maintenance system for an immune cell culture device, characterized in that: The intelligent control and operation and maintenance system includes a memory and a processor, wherein the memory stores an intelligent control and operation and maintenance method program. When the intelligent control and operation and maintenance method program is executed by the processor, the intelligent control and operation and maintenance method steps as described in claim 1 are implemented.
